Figure 2
From: Scope of nanotechnology in ovarian cancer therapeutics
Improved and sustained therapuetic effect of chemotherapuetic agents using nanotechnology. (A) Oral or intravenous route delivery of conventional formulations and nanocarriers. (B) Pictorial structures of various drug delivery devices such as polymer-drug conjugates, dendrimer, polymer micelle, polymer nanoparticles, and lipid nanoparticles/capsules. (C) Immunoconjugate nanosystems route for improved therapeutic efficacy.